Search research articles
Contact Us
Filters
Showing results (341-350 of 381) with videos related to
Page
of 39
Sort By:
Archives of Toxicology
|
March 6, 2022
The role of endogenous versus exogenous sources in the exposome of putative genotoxins and consequences for risk assessment
Ivonne M C M Rietjens, Arand Michael, Hermann M Bolt, et al.
The Journal of Experimental Medicine
|
February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
E Jäger, Y T Chen, J W Drijfhout, et al.
The EMBO Journal
|
May 30, 2003
Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site
Michael Arand, B Martin Hallberg, Jinyu Zou, et al.
Scientific Reports
|
November 24, 2020
Lithocholic bile acid induces apoptosis in human nephroblastoma cells: a non-selective treatment option
Julian Trah, Jonas Arand, Jun Oh, et al.
Cancer Immunity
|
December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones
Eduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.
Journal of Molecular Biology
|
October 20, 2004
Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactose
A L Rojas, R A P Nagem, K N Neustroev, et al.
Journal of Lipid Research
|
July 17, 2012
EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides
Martina Decker, Magdalena Adamska, Annette Cronin, et al.
Archives of Toxicology
|
July 18, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial
Christiane Kuhl, Stefanie Weigel, Simone Schrading, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
E Jäger, S Gnjatic, Y Nagata, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 381) with videos related to
Sort By:
Page
of 39
Archives of Toxicology
|
March 6, 2022
The role of endogenous versus exogenous sources in the exposome of putative genotoxins and consequences for risk assessment
Ivonne M C M Rietjens, Arand Michael, Hermann M Bolt, et al.
The Journal of Experimental Medicine
|
February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
E Jäger, Y T Chen, J W Drijfhout, et al.
The EMBO Journal
|
May 30, 2003
Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site
Michael Arand, B Martin Hallberg, Jinyu Zou, et al.
Scientific Reports
|
November 24, 2020
Lithocholic bile acid induces apoptosis in human nephroblastoma cells: a non-selective treatment option
Julian Trah, Jonas Arand, Jun Oh, et al.
Cancer Immunity
|
December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones
Eduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.
Journal of Molecular Biology
|
October 20, 2004
Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactose
A L Rojas, R A P Nagem, K N Neustroev, et al.
Journal of Lipid Research
|
July 17, 2012
EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides
Martina Decker, Magdalena Adamska, Annette Cronin, et al.
Archives of Toxicology
|
July 18, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial
Christiane Kuhl, Stefanie Weigel, Simone Schrading, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
E Jäger, S Gnjatic, Y Nagata, et al.
Page
of 39